Fujian Cosunter Pharmaceutical Co., Ltd.

¥75.73As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300436Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.26%
Div yield —
ROE (33.92%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.24
PE TTM —
TSR TTM (37.91%)
Mkt cap ¥12.72B
ROIC (21.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥75
(1.41%)
(82.62%)
Hold 3|7|11|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.29
1.32
1.28
1.24
17.82%
8.06%
6.86%
0.97%
Revenue¥M
634.0
634.3
667.7
662.8
14.26%
12.33%
15.89%
9.92%
Peers (US$1.907B)
Cap (US$)
PE
1.926B
13.11x
1.879B
72.96x
Capital
TTM
5Y
10Y
Leveragex
1.134
0.407
0.351
EBIT/Intx
1.046
0.075
0.075
Own earn%
77.89
49.28
60.56
Sh yield%
18.06
55.79
53.74
Owners
Insiders/Inst%
5.44
88.92
Short interest%
2.86
SBC / revenue%
0.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–8
$1 testx
—
Incr. ROIC%
0